[1]曹雯,郑仁东,陈国芳,等.甲状腺功能亢进症伴严重药物性胆汁郁积性肝炎1例并文献复习[J].国际内分泌代谢杂志,2014,(03):214-216.[doi:10.3760/cma.j.issn.1673-4157.2014.03.020]
 Cao Wen,Zheng Rendong,Chen Guofang,et al.One case of hyperthyroidism with severe drug-induced cholestasis hepatitis and literature review[J].International Journal of Endocrinology and Metabolism,2014,(03):214-216.[doi:10.3760/cma.j.issn.1673-4157.2014.03.020]
点击复制

甲状腺功能亢进症伴严重药物性胆汁郁积性肝炎1例并文献复习()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2014年03期
页码:
214-216
栏目:
病例报道
出版日期:
2014-06-30

文章信息/Info

Title:
One case of hyperthyroidism with severe drug-induced cholestasis hepatitis and literature review
作者:
曹雯郑仁东陈国芳包薇萍刘超
210028 南京,中国中医科学院江苏分院,南京中医药大学附属中西医结合医院内分泌代谢病院区   
Author(s):
Cao WenZheng RendongChen GuofangBao WeipingLiu Chao.
Endocrine and Diabetes Center,Jiangsu Province Hospital on Integration of Chinese and Western Medicine,Nanjing University of Traditional Chinese Medicine,Jiangsu Branch of China Academy of Chinese Medical Science,Nanjing 210028,China Corresponding author:
关键词:
甲状腺功能亢进症药物性胆汁郁积性肝炎糖皮质激素
Keywords:
HyperthyroidismDrug-induced cholestasis hepatitisGlucocorticoids
DOI:
10.3760/cma.j.issn.1673-4157.2014.03.020
摘要:
甲状腺功能亢进症(甲亢)本身可导致肝功能损害,而抗甲状腺药物亦可引起肝功能损伤。但出现严重药物性胆汁郁积性肝炎的病例比较少见,临床治疗较为困难。本院收治1例,在治疗甲亢的基础上,采用甲强龙静脉脉冲冲击联合口服强的松的方案,降低患者胆红素水平,使肝功能恢复正常,甲亢亦得以控制。
Abstract:
Hyperthyroidism can cause liver damage,while anti-thyroid drugs can also cause liver dysfunction. Severe case of drug-induced cholestasis hepatitis is rare,difficult to treat. Here we report a case with drug-induced cholestasis hepatitis. On the basis of the treatment of hyperthyroidism,intravenous methyl-prednisolone pulse therapy combined with oral prednisone was used to reduce bilirubin levels in patients,the- refore the liver function of the patient returned back to normal,and the hyperthyroidism was controlled.

参考文献/References:

 [1] AydemirS,Bayraktaroglu T,Demircan N,et al.Effect of hyper-thyroidism and propylthiouracil treatment on liver biochemical tests[J].Int J Clin Pract,2005,59(11):1304-1308.  
[2] Narsing Rao L,Jacob JJ,Paul TV,et a1.Effects of pioglitazone on menstrual frequency,hyperandrogenism and insulin resistance in adoloscents and young adults with polycystic ovary syndrome[J].J Pediatr Adolesc Gynecol,2009,22(2):91-95.  
[3] 陈家伦.临床内分泌学[M].上海:上海科学技术出版社,2011, 337-346.  
[4] Ekpebegh CO,Levitt NS.A 40-year-old woman who developed jaundice during therapy for thyrotoxicosis[J].PLoS Med,2006,3(1):e12.  
[5] 田丽艳,陆伦根,陈成伟.药物性胆汁淤积[J].肝脏,2012,17(1):41-43.  
[6] 陈灏珠,林果为,王吉耀.实用内科学[M].北京:人民卫生出版社,2010,1825-2001.  
[7] 蔡晓波,范建高.常用内分泌疾病治疗药物对肝脏的影响[J].世界临床药物,2011,32(9):518-520,525.  
[8] Woeber KA.Methimazole-induced hepatotoxicity[J].Endocr Pract,2002,8(3):222-224.  
[9] Kusnecov AW,Rossi-George A.Potentiation of interleukin-1beta adjuvant effects on the humoral immune response to antigen in adrenalectomized mice[J].Neuroimmunomodulation,2001,9(2):109-118.
[10] Turnbull AV,Prehar S,Kennedy AR,et al.Interleukin-6 is an afferent signal to the hypothalamo-pituitary-adrenal axis during local inflammation in mice[J].Endocrinology,2003,144(5):1894- 1906.

相似文献/References:

[1]陈堃,陈国芳,郑仁东,等.碳酸锂对甲状腺功能和形态的影响[J].国际内分泌代谢杂志,2014,(04):248.[doi:10.3760/cma.j.issn.1673-4157.2014.04.009]
 Chen Kun,Chen Guofang,Zheng Rendong,et al.Effects of carbonate lithium therapy on morphology and function of thyroid gland[J].International Journal of Endocrinology and Metabolism,2014,(03):248.[doi:10.3760/cma.j.issn.1673-4157.2014.04.009]
[2]龙丽 张秀英 纪立农.甲状腺相关眼病治疗新希望——IGF-Ⅰ受体拮抗剂[J].国际内分泌代谢杂志,2022,42(04):256.[doi:10.3760/cma.j.cn121383-20210420-04055]
 Long Li,Zhang Xiuying,Ji Linong..New hope for the treatment of thyroid associated orbitopathy-IGF-Ⅰ receptor antagonist[J].International Journal of Endocrinology and Metabolism,2022,42(03):256.[doi:10.3760/cma.j.cn121383-20210420-04055]
[3].中国甲状腺功能亢进症和其他原因 所致甲状腺毒症诊治指南[J].国际内分泌代谢杂志,2022,42(05):401.[doi:10.3760/cma.j.cn311282-20220624-00404]
[4]邢渝敏,单忠艳.碘营养与甲状腺功能亢进症:共识与争议[J].国际内分泌代谢杂志,2023,43(04):287.[doi:10.3760/cma.j.cn121383-20230508-05010]
 Xing Yumin,Shan Zhongyan.Iodine nutrition and hyperthyroidism: consensus and controversy[J].International Journal of Endocrinology and Metabolism,2023,43(03):287.[doi:10.3760/cma.j.cn121383-20230508-05010]

备注/Memo

备注/Memo:
通信作者:刘超,Email: liuchao@nfmcn.com
更新日期/Last Update: 2014-05-20